ACTH-012A

ACTH-012A
Product Description

Cpc provides wide range of products which includes acth-012a. Category: adrenocorticotropic hormones (acth). Contact us for more information.

CPC Scientific.Inc

  • US
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
CMO/CDMO
Specifications
  • Details
    Molecular formula:C97H147N29O24S1. molecular Weight:2135.5
  • Selling Points
    Experienced Technicians; Prompt Delivery; Quality Service
  • Supplied from
    United States

CPC Scientific.Inc

  • US
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
CMO/CDMO

More Products from CPC Scientific.Inc (99)

  • ACTH-009A

    Product ACTH-009A

    Cpc provides wide range of products which includes acth-009a. Category: adrenocorticotropic hormones (acth). Contact us for more information.
  • MSH-B 1mg

    Product MSH-B 1mg

    Chinese peptide co provides wide range of products which includes msh-b 1mg. It belongs tomelanocyte-stimulating hormone (msh) and msh-seque category. Contact us for more information.
  • ACTH-010A

    Product ACTH-010A

    Cpc provides wide range of products which includes acth-010a. Category: adrenocorticotropic hormones (acth). Contact us for more information.
  • Myelin Basic Protein (87-99) (human, bovine, rat) 1mg

    Product Myelin Basic Protein (87-99) (human, bovine, rat) 1mg

    Chinese peptide co provides wide range of products which includes myelin basic protein (87-99) (human, bovine, rat) 1mg. It belongs tomyelin basic protein fragments and antagonists category. Contact us for more information.
  • ACTH-011A

    Product ACTH-011A

    Cpc provides wide range of products which includes acth-011a. Category: adrenocorticotropic hormones (acth). Contact us for more information.
  • Myelin Basic Protein (87-99) (human, bovine, rat) 5mg

    Product Myelin Basic Protein (87-99) (human, bovine, rat) 5mg

    Chinese peptide co provides wide range of products which includes myelin basic protein (87-99) (human, bovine, rat) 5mg. It belongs tomyelin basic protein fragments and antagonists category. Contact us for more information.
  • Myelin Oligodendrocyte Glycoprotein (35-55) (human) MOG (35-55) (human) 0.5mg

    Product Myelin Oligodendrocyte Glycoprotein (35-55) (human) MOG (35-55) (human) 0.5mg

    Chinese peptide co provides wide range of products which includes myelin oligodendrocyte glycoprotein (35-55) (human) mog (35-55) (human) 0.5mg. It belongs tomog category. Contact us for more information.
  • ?-Amyloid (1-40), rat 0.5mg

    Product ?-Amyloid (1-40), rat 0.5mg

    Chinese peptide co provides wide range of products which includes ?-amyloid (1-40), rat 0.5mg. It belongs to?-amyloids and related peptides category. Contact us for more information.
  • ACTH-013A

    Product ACTH-013A

    Cpc provides wide range of products which includes acth-013a. Category: adrenocorticotropic hormones (acth). Contact us for more information.
  • ?-Amyloid (17-40) 1mg

    Product ?-Amyloid (17-40) 1mg

    Chinese peptide co provides wide range of products which includes ?-amyloid (17-40) 1mg. It belongs to?-amyloids and related peptides category. Contact us for more information.
  • ACTH-014A

    Product ACTH-014A

    Cpc provides wide range of products which includes acth-014a. Category: adrenocorticotropic hormones (acth). Contact us for more information.
  • ?-Amyloid (40-1) 0.05mg

    Product ?-Amyloid (40-1) 0.05mg

    Chinese peptide co provides wide range of products which includes ?-amyloid (40-1) 0.05mg. It belongs to?-amyloids and related peptides category. Contact us for more information.

CPC Scientific.Inc resources (1)

  • News Terlipressin Formulation with API Manufactured by CPC Scientific Approved for Further Study by the MEB

    SAN JOSE, CA., Feb 1, 2021 /CPCNewswire/ — CPC Scientific Inc. is pleased to announce that the Dutch Medicines Evaluation Board (MEB) has completed its technical review of their client’s drug product and formulation process for Terlipressin. The API provided to the client is manufactured at CPC Scientific’s GMP facility. On January 18, 2021, the MEB granted approval of the drug product and will move to the next phase to review product characterization profiles, specifications, and labels in the Netherlands. The MEB is the Dutch regulatory agency responsible for assessing, monitoring, and promoting the proper use of medicines. After final approval, the drug product will be available for sale in the Netherlands and Germany.